Updated: 22-Sep-26 09:09 ET
Co: ADRX
ADARx Pharmaceuticals (Nasdaq) | Late-stage biotech company developing next-generation siRNA therapies designed to selectively silence disease-driving genes and treat a range of chronic diseases | Initial Shares: 21.9 M | Initial Range: $15.00-$17.00 | Priced On: NA | Opened: NA | Underwriters: Lead: JP Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, and LifeSci Capital
Co: AMRO
Amaero (Nasdaq) | Producer of high-purity titanium and refractory metal powders for additive manufacturing and large-scale PM-HIP components serving defense, aerospace, and other advanced manufacturing markets | Initial Shares: 7.5 M | Initial Range: $7.06 | Priced On: NA | Opened: NA | Underwriters: Lead: Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co.
Co: BMB
Bamboo Insurance Servics (NYSE) | AI and technology-enabled, underwriting-first and capital-light homeowners insurance MGU | Initial Shares: 35.0 M | Initial Range: $18.00-$20.00 | Priced On: NA | Opened: NA | Underwriters: Lead: J.P.Morgan, Morgan Stanley, Deutsche Bank Securities, Evercore ISI, Wells Fargo Securities
Co: OURA
ŌURA (Nasdaq) | Health technology company that develops smart rings and a digital health platform to continuously track and analyze sleep, activity, stress, heart health and other wellness metrics | Initial Shares: 50.0 M | Initial Range: $40.00-$44.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Goldman Sachs & Co. LLC, Morgan Stanley, J.P. Morgan, Allen & Company LLC, and Jefferies
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.